Transplant Critical Care Group
Acute or chronic organ failure is associated with high morbidity and mortality. Organ transplantation is currently the treatment of choice In many patients with end-stage organ insufficiency or acute failure with no chance of spontaneous recovery. Intensive care medicine, providing causal and supportive organ support therapy, plays an important role in the treatment of organ donors and recipients.
The main focus of our scientific work concentrates on artificial extracorporeal organ support as a bridge to recovery and/or to transplantation in either acute organ failure or in primary poor post-transplant graft function. We are interested in the pathophysiological changes, effects on haemodynamics, interleukine profiles and coagulation system in patients supported with molecular adsorbent recirculating system (MARS), continuous venovenous haemodialysis, cytokine adsorbers, extracorporeal oxygenation (ECMO) and interventional lung assist (ILA).
Furthermore, clinical monitoring at a bedside (transesophageal echocardiography in liver transplantation, anticoagulation monitoring) in the perioperative period in clinical transplantation is of great interest for our group.